Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has shared an announcement.
Suzhou Basecare Medical Corporation Limited plans to implement an H share full circulation scheme by converting 190,812,165 domestic unlisted shares into H shares tradable on the Hong Kong Stock Exchange. The move, which does not require further shareholder approval under the company’s articles, is subject to filings with the China Securities Regulatory Commission, approval from the Hong Kong exchange, and other regulatory clearances, and is intended to expand the company’s freely tradable share base while warning investors to exercise caution until approvals are secured.
The board has approved the proposal in principle but has yet to complete the CSRC filing, submit a formal application for conversion and listing, or finalize detailed implementation arrangements. The planned conversion and listing could enhance liquidity and align the company with China’s full circulation policy for H-share issuers, potentially affecting shareholder structure and market trading dynamics once regulatory processes are completed.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corporation Limited is a medical company incorporated in the People’s Republic of China and listed in Hong Kong under stock code 2170. The group operates in the healthcare sector, focusing on medical products and services, and accesses international capital markets through its H-share listing on the Hong Kong Stock Exchange.
Average Trading Volume: 109,363
Technical Sentiment Signal: Sell
Current Market Cap: HK$527.9M
For a thorough assessment of 2170 stock, go to TipRanks’ Stock Analysis page.